FOLR1 and breast carcinoma: We did observe a significant difference in median FOLR1 expression between patients age (≤60, P = 0.002) when analysis was performed across all breast cancer subtypes (S2 Table), but this significance was lost when analysis was limited to TNBC tumors (S3 Table).